Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 12/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16484266 | 0.94 | HTR1A (0.38) | GRM5HTR1AHTR7DHFRMCL1 | |
| SCHEMBL17109006 | 0.89 | GRM5 (0.42) | GRM5HTR1AHTR7DHFRMCL1 | |
| SCHEMBL17108972 | 0.87 | GRM5 (0.41) | GRM5HTR1AHTR7DHFR | |
| SCHEMBL21453997 | 0.87 | L3MBTL1 (0.42) | GRM5 | |
| SCHEMBL17108991 | 0.86 | GRM5 (0.40) | GRM5HTR1AHTR7DHFRCYP2A6 | |
| SCHEMBL17175216 | 0.82 | GRM5 (0.44) | GRM5HTR1AHTR7DHFRCYP2A6 | |
| SCHEMBL17109002 | 0.82 | NPC1 (0.33) | — | |
| SCHEMBL9955519 | 0.81 | HTR1A (0.43) | GRM5HTR1AHTR7DHFRMCL1 | |
| SCHEMBL17248289 | 0.81 | HTR1A (0.47) | GRM5HTR1AHTR7DHFR | |
| SCHEMBL17109004 | 0.80 | HTR1A (0.33) | GRM5HTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| WO-2014057684-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 出光興産株式会社 (JP) | 2014-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | YBX1, ATXN2L, ATXN2 | GRM5 2345/4885HTR1A 1317/4885HTR7 2019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.